[Home ] [Archive]    
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: year 16, Issue 66 (2-2025) ::
3 2025, 16(66): 41-49 Back to browse issues page
Kidney injury molecule-1 (KIM-1) a potential biomarker for early detection of AKI in neonates
Fariba Nabatchian1 , Parmis Zand2 , Asal Taraghikhah2 , Toranj Sharifpour2
1- Department of Laboratory Sciences, Faculty of Paramedical Sciences, Tehran University of Medical Sciences
2- Faculty of Paramedical Sciences, Tehran University of Medical Sciences
Abstract:   (556 Views)
Background: Acute kidney injury (AKI) is a serious condition in critically ill newborns, marked by a sudden decline in kidney function. Traditionally, it is diagnosed using serum creatinine (Scr) levels, but Scr is not sensitive enough for early detection. This highlights the urgent need for more reliable biomarkers. This study explores kidney injury molecule-1 (KIM-1) as a potential early indicator of AKI in neonates receiving intensive care.
Method: This systematic review and meta-analysis adhered to PRISMA and Cochrane guidelines. A systematic search was conducted in databases such as PubMed, Scopus, and Web of Science, along with Google Scholar, using keywords and MeSH terms related to “KIM-1,” “Neonates,” and “AKI.” Two independent investigators performed searches and data extraction, resolving conflicts with a third author. The inclusion criteria focused on observational studies evaluating KIM-1 for AKI diagnosis in critically ill neonates, while exclusions encompassed reviews, animal studies, conference papers, book chapters, letters, trials, studies lacking a control group, and adult studies. Study quality was appraised using the Newcastle-Ottawa Scale, and heterogeneity was determined via I² statistics. Findings were reported as weighted mean differences (WMDs) and pooled area under the curve (AUC) with 95% confidence intervals (CI). Statistical analyses were performed using Stata 14.2.
Results: Out of 201 studies, 186 were excluded (114 duplicates, 72 irrelevant). In the end, 14 studies (10 case-control and 4 cohort studies) met the criteria for inclusion. The total sample consisted of 675 critically ill neonates, of whom 283 (42%) had AKI and 392 (58%) were in the control group. KIM-1 levels were significantly higher in neonates with AKI compared to those without (WMD = 0.91; 95% CI = 0.05-1.77; I² = 95.7%; Z = 2.07; P = 0.038). The pooled AUC was 0.72 (95% CI = 0.64-0.80; I² = 0%), indicating a moderate ability of KIM-1 to distinguish between AKI and non-AKI cases.
Conclusion: These findings suggest that KIM-1 could be a promising biomarker for the early detection of AKI in critically ill neonates, offering a potential improvement over traditional diagnostic methods.
Keywords: KIM-1, neonate, AKI, critically ill
Full-Text [PDF 1070 kb]   (209 Downloads)    
Type of Study: Review | Subject: بیوشیمی
Received: 2025/03/11 | Accepted: 2025/03/11 | Published: 2025/03/11
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nabatchian F, Zand P, Taraghikhah A, Sharifpour T. Kidney injury molecule-1 (KIM-1) a potential biomarker for early detection of AKI in neonates. 3 2025; 16 (66) :41-49
URL: http://labdiagnosis.ir/article-1-593-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
year 16, Issue 66 (2-2025) Back to browse issues page
Laboratory and Diagnosis
Persian site map - English site map - Created in 0.05 seconds with 36 queries by YEKTAWEB 4710